Navigation Links
Relief from Menopause Symptoms Short-lived for Prempro Women Suffering from Cancers
Date:7/10/2012

CRESSKILL, N.J., July 10, 2012 /PRNewswire/ -- Prempro promised women relief from menopause symptoms, but the relief was short-lived for the estimated 10,000 plaintiffs who developed breast cancer after taking the drug. Pfizer, which purchased Prempro's original manufacturer, Wyeth, has set aside $330 million to settle 4,000 remaining suits after already settling some 6,000 suits for $896 million. The settlements come after six years of trials in which courts found Pfizer and Wyeth guilty of "wanton and reckless" behavior (http://www.drdach.com/Prempro_Dangerous.html). As it may take months, if not years, for the settlements to be disbursed, RD Legal Funding, LLC ("RD Legal") is offering the plaintiffs, and their attorneys, legal settlement funding as soon as settlement amounts have been finalized.

(Logo: http://photos.prnewswire.com/prnh/20110803/NY45278LOGO )

Prempro became the most prescribed drug in the Unites States despite conflicting studies, some claiming the drugs' health benefits and others warning of significant health risks. Prescribed originally to reduce menopausal side effects including hot flashes, Prempro is a Hormone Replacement Therapy (HRT) combining an existing Wyeth product called Premarin (conjugated equine estrogen: estrogen derived from the urine of pregnant female horses), and Provera (medroxyprogesterone acetate, a powerful synthetic progesterone).

At least 6 million women used Prempro. Sales reached $2 billion a year in 2001 before a federal study reported in 2002 that Prempro increased the incidence of breast cancer by 26 percent, heart attack by 29 percent, stroke by 41 percent, and blood clots in the legs and veins by 105 percent. A number of other adverse health consequences including ovarian and gall bladder cancer, lupus, non-Hodgkin's lymphoma, scleroderma, venous thrombosis, pulmonary embolism, and asthma were also recorded.

Lawsuits by cancer-stricken women who had taken Prempro were lodged against Wyeth, claiming the company oversold the benefits of the drug while failing to warn of the risks. Wyeth was forced to turn over documents revealing that between 1997 and 2005, they spent tens of millions of dollars promoting Prempro with positive preventive health messages designed to counter negative messages emerging from the scientific community.

Celebrities including Lauren Hutton and Patti LaBelle were paid to endorse Prempro. Wyeth used ghostwriters to produce some 40 articles, including reviews of prior studies, promoting hormone replacement for treatment of menopause symptoms and other illnesses, including Parkinson's disease and dementia, for which there was no clinical evidence that the drug had any positive effects. Influential doctors were paid to use their names as authors on studies published in 18 different medical journals, none of which were informed that the drug manufacturer had funded the studies. Wyeth marketed its HRT products directly to one million HRT users through "Seasons," its own pro-HRT magazine, and brochures in doctors' lobbies, declaring "Menopause isn't gone in a flash—its debilitating consequences can affect the rest of your life."

The women who followed their doctors and celebrities' advice to take Prempro have seen their life-expectancy significantly shortened. To get settlement financing to them as quickly as possible, they or their attorneys should contact RD Legal at 1-800-565-5177 for more information about immediate settlement funding. Once the necessary documentation is received, RD Legal can wire funds within days. RD Legal provides personalized service and quick turnaround.

Founded in 1997, RD Legal has established itself as one of the nation's leading providers of lawsuit settlement funding to attorneys and plaintiffs. Contact RD Legal at 1-800-565-5177 or visit http://www.legalfunding.com for more information.

Social media links for RD Legal: Facebook, Twitter, Google+


SOURCES:

http://www.aboutlawsuits.com/hrt-increases-risk-of-breast-cancer-blood-clots-and-stroke-study-27971/

http://annals.org/article.aspx?doi=10.7326/0003-4819-157-2-201207170-00466

http://www.lawyersandsettlements.com/lawsuit/prempro.html#.T-dAOvVe_l8

http://www.consumerjusticefoundation.com/20120426658/legal/pfizer-breast-cancer-lawsuit

http://www.prnewswire.com/news-releases/lowest-effective-dose-of-premprotm-03-mg15-mg-now-readily-available-in-the-united-states---trend-toward-lower-dose-hormone-therapy-continues-71730407.html

http://www.huffingtonpost.com/david-katz-md/hormone-replacement-_b_847884.html

http://www.ncbi.nlm.nih.gov/pubmed/9718051

http://www.ncbi.nlm.nih.gov/pubmed/12117397

http://www.yourlawyer.com/articles/read/18855

http://www.lexisnexis.com/community/litigationresourcecenter/blogs/litigationblog/archive/2012/04/19/4-million-in-compensatory-damages-awarded-by-connecticut-jury-in-prempro-breast-cancer-trial.aspx

http://www.ctlawtribune.com/PubArticleCT.jsp?ID=42032&slreturn=1

http://www.totalinjury.com/news/articles/drug-companies/wyeth-product-liablity.aspx

http://www.nytimes.com/2009/11/24/business/24wyeth.html

http://money.cnn.com/2006/04/26/news/companies/wyeth/index.htm

 


'/>"/>
SOURCE RD Legal Funding, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
3. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
4. Direct Relief Delivers Hurricane Packs As FEMA Urges Preparedness
5. MLB All-Star Pitcher CC Sabathia Issues Fast Relief Challenge to Generate Donations for the American Red Cross
6. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
7. NAMS Journal Menopause Reflects on the WHI 10 Years Later
8. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
9. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
10. Sorbent Therapeutics CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
11. Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... 9, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... today announced it has earned a spot on ... The Company was ranked among 500 U.S. employers as ... Healthcare Equipment and Services. The annual ... anonymous, independent survey of over 30,000 employees across 25 ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/8/2017)... , May 8, 2017 MACRA replaces ... from fee for service reimbursement. Black Book Research crowdsource-surveyed ... 1.       The Market for MIPS Compliance Technology ... of physician practices with 3 or more clinicians seek ... by Q4. "Given the magnitude of the changes, the ...
Breaking Medicine Technology:
(Date:5/27/2017)... TX (PRWEB) , ... May 27, 2017 , ... Hate visiting the dentist? You should ... you'll need to take care of your teeth at home. Here are some dental tips ... after meals. Keep a small toothbrush in your work desk or a locker at school ...
(Date:5/27/2017)... ... 2017 , ... Most us are familiar with the sound of occasional popping ... Osteoarthritis Initiative shows that certain people who experience consistent joint popping, grating and ... doctors the opportunity to treat patients before the problem becomes pronounced, potentially hedging off ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... at Boston CEO 2017 on May 30th and 31st at The Four Seasons ... for leading executives in the life sciences, offering exclusive access to key decision ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... 26, 2017 , ... via seating is proud to partner ... chair specifically designed for clinical areas. Genie Copper Mesh is a crossover chair ... to provide customers with a game changing chair that is affordably priced,” Chas ...
Breaking Medicine News(10 mins):